LAURITZ LYKKE SMED INVEST ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.3% 2.7% 2.6% 1.0% 3.6%  
Credit score (0-100)  66 60 60 87 51  
Credit rating  BBB BBB BBB A BBB  
Credit limit (kDKK)  0.0 0.0 0.0 1,097.2 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -23.0 -48.7 -1,182 -669 -754  
EBITDA  -23.0 -48.7 -1,182 -669 -754  
EBIT  -23.0 -48.7 -1,182 -669 -754  
Pre-tax profit (PTP)  1,385.7 6,871.3 8,756.7 1,872.7 -2,309.9  
Net earnings  1,385.7 6,871.3 8,756.7 1,872.7 -2,309.9  
Pre-tax profit without non-rec. items  1,386 6,871 8,757 1,873 -2,310  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  777 7,649 16,405 18,278 15,968  
Interest-bearing liabilities  3,375 1,003 13.5 240 0.0  
Balance sheet total (assets)  4,217 9,830 21,576 23,660 18,316  

Net Debt  3,369 982 13.4 191 -1.3  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -23.0 -48.7 -1,182 -669 -754  
Gross profit growth  82.7% -111.7% -2,328.1% 43.4% -12.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,217 9,830 21,576 23,660 18,316  
Balance sheet change%  62.4% 133.1% 119.5% 9.7% -22.6%  
Added value  -23.0 -48.7 -1,181.9 -669.0 -753.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  37.9% 98.1% 55.8% 8.5% -11.0%  
ROI %  38.6% 107.6% 69.9% 11.0% -13.4%  
ROE %  82.1% 163.1% 72.8% 10.8% -13.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  18.4% 77.8% 76.0% 77.3% 87.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -14,651.4% -2,016.6% -1.1% -28.5% 0.2%  
Gearing %  434.2% 13.1% 0.1% 1.3% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.6% 0.8% 0.2% 35.8% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.7 0.6 1.3 1.1 1.0  
Current Ratio  0.7 0.6 1.3 1.1 1.0  
Cash and cash equivalent  5.7 21.8 0.1 49.4 1.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -685.9 -486.9 1,386.1 544.0 -107.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0